Haruki Horiguchi
11PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Apr 03, 2026
Reevaluating the senolytic activity of a GLS1 inhibitor and an anti-PD-1 antibody: toward greater reproducibility and methodological rigor.Shimpei Kawamoto, Haruki Horiguchi, Daisuke Torigoe
|Dec 17, 2024
The Two Faces of Angiopoietin-Like Protein 2 in Cancer.Haruki Horiguchi, Tsuyoshi Kadomatsu, Yuichi Oike
|Oct 31, 2024
Immunotherapy-induced reprogramming of cancer-associated fibroblasts can promote tumor progression.Tomoya Yamashita, Haruki Horiguchi, Tsuyoshi Kadomatsu
|Sep 25, 2024
Host ANGPTL2 establishes an immunosuppressive tumor microenvironment and resistance to immune checkpoint therapy.Shinsei Yumoto, Haruki Horiguchi, Tsuyoshi Kadomatsu
|Mar 12, 2024
Tumor stroma-derived ANGPTL2 potentiates immune checkpoint inhibitor efficacy.Haruki Horiguchi, Tsuyoshi Kadomatsu, Tomoya Yamashita
|Sep 22, 2023
ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis.Haruki Horiguchi, Tsuyoshi Kadomatsu, Tomoya Yamashita
Pageof 2
Frequent Collaborators
8 joint publications
Tsuyoshi Kadomatsu
6 joint publications
Yuichi Oike
4 joint publications
Michio Sato
4 joint publications
Toshiro Moroishi
3 joint publications
Keishi Miyata
2 joint publications
Taichi Horino
1 joint publications
Motoyoshi Endo
1 joint publications
Takeshi Masuda
1 joint publications
Jun Morinaga
1 joint publications
Kenichi Aizawa
